Holen Sie sich die Stockscreener-App
69.79
1.42%
0.98
Handel nachbörslich:
70.00
0.21
+0.30%
Schlusskurs vom Vortag:
$68.81
Offen:
$68.76
24-Stunden-Volumen:
460.49K
Relative Volume:
0.69
Marktkapitalisierung:
$2.95B
Einnahmen:
$17.39M
Nettoeinkommen (Verlust:
$-135.89M
KGV:
-15.04
EPS:
-4.64
Netto-Cashflow:
$-123.00M
1W Leistung:
+2.38%
1M Leistung:
+7.09%
6M Leistung:
+47.36%
1J Leistung:
+47.55%
1-Tages-Spanne:
$67.50
$70.16
1-Wochen-Bereich:
$66.31
$70.84
52-Wochen-Spanne:
$38.51
$76.81
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
Firmenname
Tarsus Pharmaceuticals Inc
Sektor
Branche
Telefon
(949) 409-9820
Adresse
15440 LAGUNA CANYON ROAD, IRVINE
Vergleichen Sie TARS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
69.79 | 2.90B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2023-11-20 | Eingeleitet | Goldman | Neutral |
| 2023-07-18 | Eingeleitet | William Blair | Outperform |
| 2023-05-18 | Eingeleitet | Guggenheim | Buy |
| 2022-08-01 | Eingeleitet | Barclays | Overweight |
| 2021-12-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-23 | Eingeleitet | Oppenheimer | Outperform |
| 2020-11-10 | Eingeleitet | BofA Securities | Buy |
| 2020-11-10 | Eingeleitet | Jefferies | Buy |
| 2020-11-10 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-11-10 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Tarsus Pharmaceuticals Inc Aktie (TARS) Neueste Nachrichten
Top chart patterns to watch in Tarsus Pharmaceuticals Inc.2025 Big Picture & Long-Term Capital Growth Ideas - newser.com
Does Tarsus Pharmaceuticals Inc. fit your quant trading modelQuarterly Investment Review & Long-Term Safe Return Strategies - newser.com
Is Tarsus Pharmaceuticals Inc. stock a safe investment in uncertain marketsQuarterly Portfolio Report & Real-Time Volume Analysis - newser.com
What momentum indicators show for Tarsus Pharmaceuticals Inc. stockMarket Performance Summary & Consistent Growth Stock Picks - newser.com
Tarsus Pharmaceuticals Inc (TARS) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance
What catalysts could drive Tarsus Pharmaceuticals Inc. stock higherWeekly Trade Recap & Breakout Confirmation Alerts - newser.com
What's Next For Tarsus As Cash Reserves Fuel Pipeline And Global Reach? - RTTNews
Is Tarsus Pharmaceuticals Inc. stock cheap at current valuationWeekly Stock Analysis & Community Verified Trade Signals - newser.com
Is Tarsus Pharmaceuticals Inc. showing signs of accumulationTreasury Yields & Low Drawdown Trading Techniques - newser.com
How analysts rate Tarsus Pharmaceuticals Inc. stock todayEarnings Performance Report & Reliable Breakout Forecasts - newser.com
Can Tarsus Pharmaceuticals Inc. stock resist market sell offsAnalyst Downgrade & Fast Entry and Exit Trade Plans - newser.com
Full technical analysis of Tarsus Pharmaceuticals Inc. stockJuly 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com
Can Tarsus Pharmaceuticals Inc. stock sustain market leadershipMarket Growth Review & Growth-Oriented Investment Plans - newser.com
Can Tarsus Pharmaceuticals Inc. recover in the next quarterQuarterly Profit Summary & High Conviction Buy Zone Picks - newser.com
Is Tarsus Pharmaceuticals Inc. stock poised for growth2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com
Forecasting Tarsus Pharmaceuticals Inc. price range with options dataEarnings Summary Report & Free Safe Capital Growth Stock Tips - newser.com
What’s the recovery path for long term holders of Tarsus Pharmaceuticals Inc.Market Risk Analysis & Growth Oriented Trade Recommendations - newser.com
Tarsus Pharmaceuticals Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Tarsus Pharmaceuticals (TARS) to Release Earnings on Tuesday - MarketBeat
What to expect from Tarsus Pharmaceuticals Inc. in the next 30 days2025 Top Gainers & Step-by-Step Trade Execution Guides - newser.com
Jennison Associates LLC Trims Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Applying sector rotation models to Tarsus Pharmaceuticals Inc.2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
Will Tarsus Pharmaceuticals Inc. stock deliver shareholder value2025 Market Overview & Weekly High Return Opportunities - newser.com
Tarsus Pharmaceuticals Inc. stock trend outlook and recovery pathGold Moves & Risk Controlled Stock Alerts - newser.com
Allianz Asset Management GmbH Purchases New Holdings in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Finanzdaten der Tarsus Pharmaceuticals Inc-Aktie (TARS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):